Production of IL-13 by human lung mast cells in response to Fcε receptor cross-linkage

Clinical and Experimental Allergy

Volumn 28, Issue 10, 1998, Pages 1219-1227

  Kobayashi, H ^a   Okayama, Y ^a,c   Ishizuka, T ^a   Pawankar, R ^b   Ra, C ^b   Mori, M ^a  

^a GUNMA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

IgE; IL 13; Mast cell; Stem cell factor

Indexed keywords

FC RECEPTOR; INTERLEUKIN 13;

ALLERGY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CROSS LINKING; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; MAST CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY;

CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-13; KINETICS; LUNG; MAST CELLS; RECEPTORS, IGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL FACTOR;

EID: 0032459482     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00377.x     Document Type: Article

References (30)

1. Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-8.
2. Sedgwick JB, Calhoun WJ, Gleich GJ et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991; 144:1274-81.
3. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
4. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176:1381-6.
5. Bradding P, Feather IH, Wilson S et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993; 151:3853-65.
6. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
7. Okayama Y, Petit-Frere C, Kassel O et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J Immunol 1995; 155:1796-808.
8. McKenzie AN, Culpepper JA, de Waal Malefyt R et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90:3735-9.
9. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
10. Defrance T, Carayon P, Billian G et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994; 179:135-43.
11. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-I expression in human endothelial cells. J Immunol 1995; 154:799-803.
12. de Waal Malefyt R, Figdor CG, Huijbens R et al. Effects of IL- 13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151:6370-81.
13. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995; 181:1373-80.
14. Ochensberger B, Daepp GC, Rihs S, Dahinden CA. Human blood basophils produce interleukin-13 in response to IgE- receptor-dependent and -independent activation. Blood 1996; 88:3028-37.
15. Jaffe JS, Raible DG, Post TJ et al. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am J Respir Cell Mol Biol 1996; 15:473-81.
16. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991; 78:30-7.
17. Okayama Y, Hunt TC, Kassel O, Ashman LK, Church MK. Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells. J Immunol Methods 1994; 169:153-61.
18. Okayama Y, Kobayashi H, Ashman LK et al. Human lung mast cells are enriched in the capacity to produce granulocyte- macrophage colony-stimulating factor in responce to IgE- dependent stimulation. Eur J Immunol 1998; 28:708-15.
19. Marshall JS, Leal-Berumen I, Nielsen L, Glibetic M, Jordana M. Interleukin (IL) -10 inhibits long-term IL-6 production hut not preformed mediator release from rat peritoneal mast cells. J Clin Invest 1996; 97:1122-8.
20. Arock M, Zuany-Amorim C, Singer M, Benhamou M, Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 1996; 26:166-70.
21. Valent P, Spanblochl E, Sperr WR et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80:2237-45.
22. Irani AM, Nilsson G, Miettinen U et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80:3009-21.
23. Bischoff SC, Dahinden CA. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med 1992; 175:237-44.
24. Columbo M, Horowitz EM, Botana LM et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE- dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992; 149:599-608.
25. Gadd SJ, Ashman LK. A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. Leuk Res 1985; 9:1329-36.
26. Essayan DM, Han WF, Li XM et al. Clonal diversity of IL-4 and IL-13 expression in human allergen-specific T lymphocytes. J Allergy Clin Immunol 1996; 98:1035-44.
27. Humbert M, Durham SR, Kimmitt P et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997; 99:657-65.
28. Pawankar RU, Okuda M, Hasegawa S et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995; 152:2059-67.
29. Jaffe JS, Glaum MC, Raible DG et al. Human lung mast cell IL-5 gene and protein expression: temporal analysis of up- regulation following IgE-mediated activation. Am J Respir Cell Mol Biol 1995; 13:665-75.
30. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc∈RI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997; 99:1492-9.